Nd:YAG激光内界膜切开治疗Valsalva视网膜病变的疗效

晁炜静,路小楠,尹 黎,左志高,汪 洋

武警医学 ›› 2016, Vol. 27 ›› Issue (7) : 669-671.

PDF(3359 KB)
PDF(3359 KB)
武警医学 ›› 2016, Vol. 27 ›› Issue (7) : 669-671.
论著

Nd:YAG激光内界膜切开治疗Valsalva视网膜病变的疗效

  • 晁炜静,路小楠,尹 黎,左志高,汪 洋
作者信息 +

Nd:YAG laser membranotomy for Valsalva retinopathy

  • CHAO Weijing, LU Xiaonan, YIN Li,ZUO Zhigao,and WANG Yang
Author information +
文章历史 +

摘要

目的 探讨Nd:YAG激光内界膜切开治疗Valsalva视网膜病变的安全性与有效性。方法 总结Valsalva视网膜病变接受治疗的10例10眼的临床资料进行回顾分析,所有患者均行Nd:YAG激光内界膜切开术,激光初始能量为3.0~4.8 mJ。观察记录患者术前术后视力,眼压及眼底情况。结果 患眼视力由术前的手动(6例)或指数(4例)提高到术后第1天的0.1~0.5,最后视力稳定在0.8~1.2。随诊期间眼压稳定,未发现并发症。结论 Nd:YAG激光内界膜切开治疗Valsalva视网膜病变是安全有效的方法。

Abstract

Objective To report ten cases of premacular hemorrhage secondary to Valsalva retinopathy treated with Nd:YAG laser membranotomy and discuss techniques as well as the literature data.Methods Ten cases (10 eyes) of premacular hemorrhage secondary to Valsalva retinopathy were treated with Nd:YAG laser membranotomy. Power settings ranged from 3.0 to 4.8 mJ. Best-corrected visual acuity and intraocular pressure were measured.Results Visual acuity at presentation ranged from hand motion (6 patients) to counting fingers (4 patients). Visual acuity improved to 0.1 to 0.5 after laser treatment. Final visual acuity ranged from 0.8 to 1.2. No complications were noted.Conclusions Nd:YAG laser membranotomy is a non-invasive treatment option that may be successfully used to treat premacular hemorrhage secondary to Valsalva retinopathy.

关键词

Valsalva视网膜病变 / Nd:YAG激光 / 光学相干断层扫描 / 黄斑前积血

Key words

valsalva retinopathy / Nd:YAG laser / optical coherence tomography / premacular hemorrhage

引用本文

导出引用
晁炜静,路小楠,尹 黎,左志高,汪 洋. Nd:YAG激光内界膜切开治疗Valsalva视网膜病变的疗效[J]. 武警医学. 2016, 27(7): 669-671
CHAO Weijing, LU Xiaonan, YIN Li,ZUO Zhigao,and WANG Yang. Nd:YAG laser membranotomy for Valsalva retinopathy[J]. Medical Journal of the Chinese People Armed Police Forces. 2016, 27(7): 669-671
中图分类号: R774   

参考文献

[1] Fernández M G, Navarro J C, Casta o C G. Long-term evolution of Valsalva retinopathy: a case series[J].J Med Case Rep, 2012, 6(10): 346-351.
[2] Morris R, Kuhn F, Witherspoon C D, et al. Hemorrhagic macular cysts in Terson’s syndrome and its implications for macular surgery[J].Dev Ophthalmol, 1997, 29: 44-54.
[3] Duane T D. Valsalva hemorrhagic retinopathy [J]. Trans Am Ophthalmol Soc,1972,70: 298-313.
[4] Kuruvilla O, Munie M, Shah M, et al. Nd: YAG membranotomy for preretinal hemorrhage secondary to valsalva retinopathy[J]. Saudi J Ophthalmol, 2014, 28(2): 145-151.
[5] 晁炜静,刘苏冰,聂晓丽,等.准分子激光原位角膜磨镶术中发生视网膜前积血一例[J]. 中华眼科杂志, 2014, 50(2): 146-147.
[6] Tara F, Sharifi M, Hoseini E. Valsalva retinopathy in pregnancy: a case report [J]. BMC Res Notes, 2015,8:67.
[7] Ai-Mujaini A S, Montana C C. Valsalva retinopathy in pregnancy: a case report [J]. J Med Case Rep, 2008, 2: 101.
[8] Gibran S K, Kenawy N, Wong D, et al. Changes in the retinal inner limiting membrane associated with Valsalva retinopathy [J]. Br J Ophthalmol, 2007, 91(5): 701-702.
[9] Park J H, Sagong M, Chang W. Valsalva retinopathy following esophagogastroduodenoscopy under propofol sedation: a case report [J]. World J Gastroenterol, 2014, 20(11): 3056-3058.
[10] Ai Rubaie K, Arevalo J F. Valsalva retinopathy associated with sexual activity [J]. Case Rep Med, 2014, 2014: 524286.

PDF(3359 KB)

Accesses

Citation

Detail

段落导航
相关文章

/